 Codexis, Inc. CDXS, a leading protein engineering company and developer of high-performance enzymes, and Alphazyme LLC, an emerging leader in the development and manufacture of nucleic acid metabolizing enzymes, announce a Co-Marketing Enzyme Supply Collaboration Agreement for the production and co-marketing of enzymes for life science applications. The first enzyme is a high-fidelity DNA polymerase, following up on Codexis previously announced high performance DNA ligase, which was exclusively licensed to Roche in late 2019. The Codexis-developed DNA polymerase has been engineered to deliver high fidelity and uniformity of coverage, providing an accurate and representative DNA diagnostic result. 